92 related articles for article (PubMed ID: 9707250)
1. Differentiation and cathepsin D expression in human oral tumors.
Brysk MM; Lei G; Adler-Storthz K; Chen Z; Horikoshi T; Brysk H; Tyring SK; Arany I
Laryngoscope; 1998 Aug; 108(8 Pt 1):1234-7. PubMed ID: 9707250
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of cathepsin-D for cervical lymph node metastasis in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock B; Donald PJ
Head Neck; 1999 Dec; 21(8):718-22. PubMed ID: 10562684
[TBL] [Abstract][Full Text] [Related]
3. Zinc-alpha2-glycoprotein expression as a marker of differentiation in human oral tumors.
Brysk MM; Lei G; Adler-Storthz K; Chen Z; Brysk H; Tyring SK; Arany I
Cancer Lett; 1999 Mar; 137(1):117-20. PubMed ID: 10376801
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of cathepsin L and its inhibitor headpin in oral squamous cell carcinoma.
Nakashima T; Yasumatsu R; Masuda M; Clayman GL; Komune S
J Laryngol Otol; 2012 Nov; 126(11):1134-7. PubMed ID: 22963824
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of Cathepsin D in Primary and Recurrent Squamous Cell Carcinoma.
Satelur KP; Kumar GS
J Contemp Dent Pract; 2017 Sep; 18(9):795-801. PubMed ID: 28874644
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
7. Differentiation markers in oral carcinoma cell lines and tumors.
Arany I; Adler-Storthz K; Chen Z; Tyring SK; Brysk H; Brysk MM
Anticancer Res; 1997; 17(6D):4607-10. PubMed ID: 9494576
[TBL] [Abstract][Full Text] [Related]
8. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin expression in oral cancer and its relationship to tumor differentiation.
Ogden GR; Chisholm DM; Adi M; Lane EB
J Oral Pathol Med; 1993 Feb; 22(2):82-6. PubMed ID: 7680377
[TBL] [Abstract][Full Text] [Related]
10. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer.
Vigneswaran N; Zhao W; Dassanayake A; Muller S; Miller DM; Zacharias W
Hum Pathol; 2000 Aug; 31(8):931-7. PubMed ID: 10987253
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
[TBL] [Abstract][Full Text] [Related]
12. Local inflammation may influence oral tumor cell differentiation.
Arany I; Adler-Storthz K; Chen Z; Tyring SK; Brysk H; Lei G; Brysk MM
Anticancer Res; 1999; 19(2A):1065-7. PubMed ID: 10368655
[TBL] [Abstract][Full Text] [Related]
13. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of Cathepsin B in oral squamous cell carcinoma.
Yang X; Wei KJ; Zhang L; Pan HY; Li J; Chen WT; Zhong LP; Zhang ZY
Int J Oral Maxillofac Surg; 2010 Feb; 39(2):174-81. PubMed ID: 20042316
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin K modulates invasion, migration and adhesion of oral squamous cell carcinomas in vitro.
Yamashita K; Iwatake M; Okamoto K; Yamada SI; Umeda M; Tsukuba T
Oral Dis; 2017 May; 23(4):518-525. PubMed ID: 28117540
[TBL] [Abstract][Full Text] [Related]
16. Expression of the epidermal growth factor seven-transmembrane member CD97 correlates with grading and staging in human oral squamous cell carcinomas.
Mustafa T; Eckert A; Klonisch T; Kehlen A; Maurer P; Klintschar M; Erhuma M; Zschoyan R; Gimm O; Dralle H; Schubert J; Hoang-Vu C
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):108-19. PubMed ID: 15668483
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of inducible nitric oxide synthase for human buccal squamous-cell carcinomas: immunohistochemical, reverse transcription-polymerase chain reaction (RT-PCR) and in situ RT-PCR studies.
Chen YK; Hsue SS; Lin LM
Head Neck; 2002 Oct; 24(10):925-32. PubMed ID: 12369071
[TBL] [Abstract][Full Text] [Related]
18. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.
de Vicente JC; Santamarta TR; Rodrigo JP; García-Pedrero JM; Allonca E; Blanco-Lorenzo V
Virchows Arch; 2015 May; 466(5):549-58. PubMed ID: 25726183
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status.
Maeda T; Matsumura S; Hiranuma H; Jikko A; Furukawa S; Ishida T; Fuchihata H
J Clin Pathol; 1998 Oct; 51(10):771-5. PubMed ID: 10023341
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cathepsin D as prognostic predictor in breast cancer.
Barbi GP; Margallo E; Margiocco M; Paganuzzi M; Marroni P; Costanzi B; Gatteschi B; Tanara G; Spina B; Nicolò G
Oncology; 1994; 51(4):329-33. PubMed ID: 8208515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
